Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    HT Staff

    News

    FDA aims to improve access to clinical trial info

    Author:
    HT Staff
    Publish date: January 17, 2018

    The US Food and Drug Administration (FDA) says it is taking new steps to improve public access to clinical trial information. The agency is...

    • Read More

    News

    Drug’s label updated to include risk of allergic reactions

    Author:
    HT Staff
    Publish date: January 17, 2018

    The US Food and Drug Administration (FDA) and Tesaro, Inc., have updated the prescribing information for Varubi® (rolapitant) injectable emulsion...

    • Read More

    News

    FDA expands approval for arsenic trioxide

    Author:
    HT Staff
    Publish date: January 16, 2018

    The US Food and Drug Administration (FDA) has expanded the approved use of arsenic trioxide (TRISENOX®) injection. The drug is now approved for...

    • Read More

    News

    How a malaria parasite is evading treatment

    Author:
    HT Staff
    Publish date: January 15, 2018

    New research has revealed mutations that help the malaria parasite Plasmodium falciparum evade treatment. Researchers used whole-genome analyses...

    • Read More

    News

    Emicizumab still available despite legal issues

    Author:
    HT Staff
    Publish date: January 14, 2018

    The Roche Group has issued a statement reassuring the US hemophilia community that legal issues are not affecting patient access to emicizumab (...

    • Read More

    News

    Generic bortezomib available in US

    Author:
    HT Staff
    Publish date: January 13, 2018

    Fresenius Kabi has introduced its generic version of Velcade, Bortezomib for Injection, to the US market. This is the first intravenous...

    • Read More

    News

    Interventions can increase cord blood donations

    Author:
    HT Staff
    Publish date: January 12, 2018

    Simple interventions can increase cord blood donations, according to research published in Scientific Reports. Researchers saw a significant...

    • Read More

    News

    EMA recommends orphan designation for pracinostat

    Author:
    HT Staff
    Publish date: January 12, 2018

    The European Medicines Agency (EMA) has recommended that pracinostat receive orphan drug designation. Pracinostat is an oral histone deacetylase...

    • Read More

    News

    Survival differences among AYAs with blood cancers

    Author:
    HT Staff
    Publish date: January 11, 2018

    A new report has revealed differences in survival among adolescents and young adults (AYAs) with hematologic malignancies. The report includes...

    • Read More

    News

    Marine animals aid development of cytotoxicity assay

    Author:
    HT Staff
    Publish date: January 11, 2018

    Researchers have looked to deep-sea creatures with the goal of creating a better cytotoxicity assay. The team harnessed the power of enzymes...

    • Read More

    News

    DNA methylation may predict outcomes in JMML

    Author:
    HT Staff
    Publish date: January 11, 2018

    New research suggests DNA methylation may be used to predict how children with juvenile myelomonocytic leukemia (JMML) will respond to treatment...

    • Read More

    News

    Gene variants associated with high-risk pediatric ALL

    Author:
    HT Staff
    Publish date: January 10, 2018

    New research has revealed germline variations associated with high-risk acute lymphoblastic leukemia (ALL) in children. Researchers sequenced the...

    • Read More

    News

    Method prolongs lifespan of blood samples

    Author:
    HT Staff
    Publish date: January 10, 2018

    A new blood stabilization method significantly prolongs the lifespan of blood samples for microfluidic sorting and transcriptome profiling of rare...

    • Read More

    News

    Drug receives breakthrough designation for SCD

    Author:
    HT Staff
    Publish date: January 10, 2018

    The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to voxelotor (previously GBT440) for the treatment of...

    • Read More

    News

    Team finds way to target MYB in AML

    Author:
    HT Staff
    Publish date: January 9, 2018

    Researchers say they have found a way to target the oncogenic transcription factor MYB in acute myeloid leukemia (AML). By inducing the...

    • Read More

    Pages

    • « first
    • …
    • 31
    • 32
    • 33
    • 34
    • 35
    • 36
    • 37
    • 38
    • 39
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery